Age
Item
18 years or older
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0 or 1
boolean
C1520224 (UMLS CUI [1])
Therapy naive Lung squamous cell carcinoma stage IV
Item
histologically or cytologically confirmed, treatment-naïve stage iv squamous nsclc
boolean
C0919936 (UMLS CUI [1,1])
C0854994 (UMLS CUI [1,2])
Tumor tissue sample Biopsy
Item
previously obtained archival tumor tissue or tissue obtained from biopsy at screening
boolean
C0475358 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
Measurable Disease
Item
measurable disease as defined by recist v1.1
boolean
C1513041 (UMLS CUI [1])
Hematologic function | organ function
Item
adequate hematologic and end organ function
boolean
C0221130 (UMLS CUI [1])
C0678852 (UMLS CUI [2])
CNS metastases untreated
Item
active or untreated central nervous system (cns) metastasis
boolean
C0686377 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
Malignant Neoplasms | Non-Small Cell Lung Carcinoma | At risk Neoplasm Metastasis | At risk Cessation of life
Item
malignancies other than nsclc within 5 years prior to randomization, with the exception of those with a negligible risk of metastasis or death treated with expected curative outcome
boolean
C0006826 (UMLS CUI [1])
C0007131 (UMLS CUI [2])
C1444641 (UMLS CUI [3,1])
C0027627 (UMLS CUI [3,2])
C1444641 (UMLS CUI [4,1])
C0011065 (UMLS CUI [4,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Autoimmune Diseases
Item
history of autoimmune disease
boolean
C0004364 (UMLS CUI [1])
Idiopathic Pulmonary Fibrosis | Organized pneumonia | Drug-induced pneumonitis | Pneumonitis idiopathic | Pneumonitis Chest CT | Radiation Pneumonitis | Radiation Field | Fibrosis
Item
history of idiopathic pulmonary fibrosis, organizing pneumonia, drug-induced pneumonitis, idiopathic pneumonitis, or evidence of active pneumonitis on screening chest computed tomography (ct) scan, history of radiation pneumonitis in the radiation field (fibrosis) is permitted
boolean
C1800706 (UMLS CUI [1])
C0264383 (UMLS CUI [2])
C1960026 (UMLS CUI [3])
C3714636 (UMLS CUI [4,1])
C0332240 (UMLS CUI [4,2])
C3714636 (UMLS CUI [5,1])
C0202823 (UMLS CUI [5,2])
C0206063 (UMLS CUI [6])
C1882536 (UMLS CUI [7])
C0016059 (UMLS CUI [8])
HIV Seropositivity
Item
positive test for human immunodeficiency virus (hiv)
boolean
C0019699 (UMLS CUI [1])
Hepatitis B | Hepatitis C
Item
active hepatitis b or hepatitis c
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
CD137 agonists
Item
prior treatment with cd137 agonists or immune checkpoint blockade therapies, anti pd-1, and anti-pd-l1 therapeutic antibody
boolean
C0214721 (UMLS CUI [1,1])
C0243192 (UMLS CUI [1,2])
Communicable Diseases Severe
Item
severe infection within 4 weeks prior to randomization
boolean
C0009450 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Cardiovascular Diseases
Item
significant history of cardiovascular disease
boolean
C0007222 (UMLS CUI [1])